MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Ironwood Pharmaceuticals Company Profile (NASDAQ:IRWD)

Consensus Ratings for Ironwood Pharmaceuticals (NASDAQ:IRWD) (?)
Ratings Breakdown: 5 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $13.50 (10.29% upside)

Analysts' Ratings History for Ironwood Pharmaceuticals (NASDAQ:IRWD)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2016WedbushReiterated RatingNeutral$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016MizuhoBoost Price TargetBuy$15.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016JP Morgan CazenoveReiterated RatingOverweight$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016Wood & CompanyInitiated CoveragePositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016Goldman SachsInitiated CoverageNeutral$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2016BTIG ResearchReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Leerink SwannReiterated RatingHold$12.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016BarclaysLower Price TargetEqual Weight$15.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015JPMorgan Chase & Co.Lower Price TargetOverweight$23.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Cantor FitzgeraldReiterated RatingHold$13.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Bank of AmericaInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2015WallachBeth CapitalBoost Price TargetHold$15.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2014Furey Research PartnersInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Ironwood Pharmaceuticals (NASDAQ:IRWD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/9/2016Q116($0.14)($0.08)$52.97 million$66.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2016Q415($0.17)($0.10)$44.78 million$53.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.20)($0.25)$39.81 million$39.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.22)($0.34)$36.08 million$27.74 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.23)($0.24)$32.30 million$28.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q414($0.21)($0.27)$35.20 million$38.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.32)($0.30)$21.20 million$16.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2014Q214($0.36)($0.38)$15.75 million$6.84 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q1($0.44)($0.38)$8.52 million$14.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/21/2014Q413($0.50)($0.43)$7.13 million$5.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2013Q313($0.57)($0.51)$6.54 million$4.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2013Q2 2013($0.70)($0.57)$6.32 million$9.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2013Q1 2013($0.71)($0.87)$8.94 million$3.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/15/2013Q4 2012($0.49)($0.41)$16.17 million$27.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2012$0.17$0.42ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2012($0.31)($0.38)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.23)($0.34)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2012($0.11)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2011($0.20)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2011($0.18)($0.19)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2011($0.17)($0.19)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Ironwood Pharmaceuticals (NASDAQ:IRWD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.16)($0.08)($0.11)
Q2 20162($0.16)($0.12)($0.14)
Q3 20162($0.19)($0.16)($0.18)
Q4 20162($0.22)($0.16)($0.19)
Q1 20171($0.18)($0.18)($0.18)
Q2 20171($0.12)($0.12)($0.12)
Q3 20171($0.04)($0.04)($0.04)
Q4 20171$0.02$0.02$0.02
(Data provided by Zacks Investment Research)
Dividend History for Ironwood Pharmaceuticals (NASDAQ:IRWD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Ironwood Pharmaceuticals (NASDAQ:IRWD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/3/2016Lawrence S OlanoffDirectorSell2,200$12.92$28,424.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Halley E GilbertInsiderSell20,275$12.19$247,152.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Peter M HechtCEOSell120,000$10.72$1,286,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Lawrence S OlanoffDirectorSell2,200$11.11$24,442.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016Edward P OwensDirectorBuy10,000$8.32$83,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016Gina ConsylmanCAOSell420$8.50$3,570.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016Mark G CurrieInsiderSell152,154$8.53$1,297,873.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016Thomas GraneyCFOSell563$8.50$4,785.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015Peter M. HechtCEOSell73,418$11.07$812,737.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Lawrence S OlanoffDirectorSell2,200$11.77$25,894.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2015Lawrence S OlanoffDirectorSell3,725$10.97$40,863.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2015Peter M HechtCEOSell200,000$15.62$3,124,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Joseph C Cook JrDirectorSell5,883$15.54$91,421.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Bryan E RobertsDirectorSell95,998$15.20$1,459,169.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Peter M HechtCEOSell63,442$15.75$999,211.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Joseph C Cook JrDirectorSell35,500$15.60$553,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Bryan E RobertsDirectorSell19,792$15.20$300,838.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2014Bryan E RobertsDirectorSell200,000$14.24$2,848,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Michael J HigginsCOOSell50,000$14.56$728,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014Mark CurrieInsiderSell25,000$13.93$348,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2014Mark CurrieInsiderSell25,000$11.67$291,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/23/2014Mark CurrieInsiderSell20,000$14.38$287,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2014Bryan RobertsDirectorSell21,200$12.57$266,484.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014Bryan RobertsDirectorSell823,350$12.71$10,464,778.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2014Bryan RobertsDirectorSell55,450$12.01$665,954.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2013Terrance McguireDirectorSell2,083$9.11$18,976.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2013Michael J HigginsCOOSell150,000$11.74$1,761,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2013Thomas A MccourtInsiderSell40,000$17.00$680,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2012Peter M HechtCEOBuy50,000$11.65$582,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2012Fmr LlcInsiderSell19,305$13.02$251,351.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Ironwood Pharmaceuticals (NASDAQ:IRWD)
DateHeadline
06/25/16 08:32 AMStock Tracing Lower on the Week Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Engelwood Daily
06/24/16 07:18 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Earnings Glance and Target Price Review - Engelwood Daily
06/22/16 04:48 PMIronwood Pharmaceuticals (NASDAQ:IRWD) Analyst Rating Consensus - TheFounders Daily
06/21/16 04:23 PMFirst Week of February 2017 Options Trading For Ironwood Pharmaceuticals (IRWD) - Money Morning
06/17/16 07:28 AMTwo Buzzers within Traders Radar: Quest Diagnostics Incorporated (NYSE:DGX) , Ironwood Pharmaceuticals, Inc ... - Street Updates
06/15/16 04:43 PMEarnings Report: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Sunrun Inc. (NASDAQ:RUN) - Beacon Chronicle
06/15/16 09:22 AMCurrent Update on Price Fluctuations: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , DexCom, Inc. (NASDAQ:DXCM) - Street Updates
06/14/16 04:34 PMNew Market Research Report: Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic SWOT Analysis Review
06/14/16 09:31 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) And Big Pharma Partners Set To Gain on Linzess sNDA - Market Exclusive
06/13/16 04:24 PMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) And Big Pharma Partners Set To Gain on Linzess sNDA
06/10/16 07:30 AMPacira Pharmaceuticals : Technical Analysis on Drugs - Generic Equities -- Akorn, Ironwood Pharma, Catalyst Pharma, and Pacira Pharma
06/10/16 07:30 AMWhich way Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) earnings may go
06/09/16 02:19 PMHere's Why Ironwood Pharmaceuticals, Inc. Jumped 19.52% in May - A first-quarter earnings report packed with good news, and a well-received investor presentation, caused shares to move higher in May.
06/09/16 07:23 AMAllergan (AGN), Ironwood Pharma's (IRWD) Linaclotide sNDA Accepted for Review by US FDA - StreetInsider.com
06/09/16 07:01 AMIronwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review - [PR Newswire] - CAMBRIDGE, Mass. and DUBLIN, June 9, 2016 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. (IRWD) and Allergan plc (AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for the 72 mcg dose of linaclotide for use in the treatment of adults with chronic idiopathic constipation (CIC). The sNDA for the 72 mcg dose of linaclotide is based on efficacy and safety data from a double-blind, placebo-controlled Phase III clinical trial of 1,223 adult patients with CIC.
06/08/16 04:58 PMCan Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Keep Up with Analyst Expectations? - Investor Newswire
06/07/16 04:51 PMInvestors Targeted Stocks: Sangamo BioSciences, Inc. (NASDAQ:SGMO) , Ironwood Pharmaceuticals, Inc. (NASDAQ ... - Street Updates
06/07/16 07:14 AMIRONWOOD PHARMACEUTICALS INC. (NASDAQ:IRWD) Financial Condition Compared to S&P 500 - CML News
06/06/16 04:36 PMActive Stocks Need to Consider- Ironwood Pharmaceuticals (NASDAQ:IRWD), Adeptus Health (NYSE:ADPT), Mylan ... - Seneca Globe
06/06/16 03:18 PMIronwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference - [at noodls] - June 6, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Jefferies 2016 Healthcare Conference on Friday, June 10, 2016 at 2:30 ...
06/05/16 07:23 AMIronwood Pharma (IRWD) Announces Closure of Lesinurad Transaction with AstraZeneca (AZN) - StreetInsider.com
06/03/16 07:23 AMIronwood Pharmaceuticals Class A (NASDAQ:IRWD) Shorted Shares Decreased By 5.95% - HNN - Ironwood Pharmaceuticals Class A (NASDAQ:IRWD) Shorted Shares Decreased By 5.95%HNNIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has risen 15.88% since October 27, 2015 and is uptrending. It has outperformed by 14.52% the S&P500. Ironwood Pharmaceuticals, Inc. is a biotechnology company. The company has a market cap of $1.94 ...
06/03/16 07:23 AMEarnings Analysis to see: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Deutsche Bank AG (NYSE:DB) - Beacon Chronicle - Earnings Analysis to see: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Deutsche Bank AG (NYSE:DB)Beacon ChronicleLast Trade: The Company closed its last session at $13.21 with the gain of 4.1%. The market capitalization of the company is $1.89 Billion, with the average Volume of 1.62 Million. The stock currently has its 52-Week High range of $14.19 and 52-week ...and more »
06/03/16 07:02 AMIRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/03/16 01:25 AMIronwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad - [at noodls] - June 3, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that it has closed the previously-announced transaction with AstraZeneca for the exclusive ...
06/02/16 07:28 AMPrice Target by Analysts: DexCom, Inc. (NASDAQ:DXCM), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Beacon Chronicle - Price Target by Analysts: DexCom, Inc. (NASDAQ:DXCM), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Beacon ChronicleLast Trade: The Company closed its last session at $64.75 with the gain of 0.4%. The market capitalization of the company is $5.32 Billion, with the average Volume of 798.24K. The stock currently has its 52-Week High range of $103.29 and 52-week low ...and more »
06/01/16 04:59 PMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Quarterly EPS Estimate At $-0.16 - Investor Newswire - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Quarterly EPS Estimate At $-0.16Investor NewswireFirst Call stated that Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) can touch $12.71 in coming one year. For the next quarter, the per-share earnings target is $-0.16 and for ongoing fiscal at $-0.61. EPS target for next year is $-0.29 versus the mean ...and more »
06/01/16 04:05 PMIronwood Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference - [at noodls] - June 1, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Goldman Sachs 37 Annual Global Healthcare Conference on Tuesday, June ...
05/29/16 06:48 PMHold Calls Count For Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) At 4 - Investor Newswire - Hold Calls Count For Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) At 4Investor NewswireIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has a total of 4 Strong Buy recommendations and 0 Strong Sell advises as of 2016-05-28. The rating procedure used by Zacks gives scores to firms on a narrow 1-5 scale. A score close to 1-2 band is a Buy ...and more »
05/29/16 10:14 AMValeant Pharmaceuticals Intl Inc (NYSE:VRX) Has 1048 Percent Upside Potential - Ironwood Pharmaceuticals, Inc.'s (IRWD) has price-to-cash ratio of 4.00 and price to sale ratio of 9.31. The Company has gross margin of 75.30% and profit margin was negative-2.80% in trailing twelve months. A look on the firm performance, its monthly ...
05/27/16 07:12 PMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) To Report June 2016 Results - iStreetWire - iStreetWireIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) To Report June 2016 ResultsiStreetWireIronwood Pharmaceuticals, Inc. (IRWD) retreated -0.33% to reach at the floor price of $12.23 as the company is set to share its next quarterly earnings on July 12, 2016. IRWD stock trades between $12.15 and $12.37 before the earnings release. Let's ...and more »
05/26/16 07:08 PMObserving Healthcare Stocks Update: Opexa Therapeutics, Inc. (NASDAQ:OPXA) , Ironwood Pharmaceuticals, Inc ... - Is stories - Is storiesObserving Healthcare Stocks Update: Opexa Therapeutics, Inc. (NASDAQ:OPXA) , Ironwood Pharmaceuticals, Inc ...Is storiesIn most recently trading session on 5/25/2016, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) climbed +1.74% while traded on 1.73 million shares versus it's an average volume of 1.69 million shares. The company recorded the last trade with the price of ...and more »
05/26/16 12:06 AMBvf INC Decreased Stake in Ironwood Pharmaceuticals INC (NASDAQ:IRWD) by $11.80 Million as Shares Declined - CCH Daily News - Is storiesBvf INC Decreased Stake in Ironwood Pharmaceuticals INC (NASDAQ:IRWD) by $11.80 Million as Shares DeclinedCCH Daily NewsBvf Inc decreased its stake in Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) by 40.2% based on its latest 2016Q1 regulatory filing with the SEC. Bvf Inc sold 1.18M shares as the company's stock declined 1.17% while stock markets rallied. The hedge fund ...Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Quarterly EPS From Continuing Operations Stands At $-0.0926Vanguard TribuneTraders Observing Biotech Stocks: AbbVie Inc. (NYSE:ABBV) , Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Is storiesIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Latest Broker CoverageRisers & FallersWall Street Hints and News -iStreetWireall 22 news articles »
05/24/16 07:05 PMHC Stocks in Front Line: Ionis Pharmaceuticals (IONS), Ironwood Pharmaceuticals (IRWD) - share market updates (press release) - share market updates (press release)HC Stocks in Front Line: Ionis Pharmaceuticals (IONS), Ironwood Pharmaceuticals (IRWD)share market updates (press release)Shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS) ended Monday session in green amid volatile trading. The shares closed up +0.49 points or 1.46% at $34.08 with 1.37 million shares getting traded. Post opening the session at $33.35, the shares hit an ...and more »
05/24/16 12:06 AMLatest Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Target Price Suggests Stock Is Worth $12.71/Share - iStreetWire - Is storiesLatest Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Target Price Suggests Stock Is Worth $12.71/ShareiStreetWireIronwood Pharmaceuticals, Inc. (IRWD) up 9.39 per cent in the past week, is under coverage of 0 analysts who collectively recommend a hold rating on stock. 0 of the analysts have a buy or better rating; the 0 sells versus 0 underperforms. The 12 equity ...Healthcare Moving Stocks: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Ironwood Pharmaceuticals, Inc ...Is storiesall 5 news articles »
05/23/16 06:55 PMHealthcare Moving Stocks: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Ironwood Pharmaceuticals, Inc ... - Is stories - Is storiesHealthcare Moving Stocks: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Ironwood Pharmaceuticals, Inc ...Is storiesIn most recently trading session on 5/20/2016, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) climbed +1.78% while traded on 2 million shares versus it's an average volume of 1.74 million shares. The company recorded the last trade with the price of ...Latest Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Target Price Suggests Stock Is Worth $12.71/ShareiStreetWireall 4 news articles »
05/22/16 11:28 PMNext Weeks Broker Price Targets For Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Share Trading News - Next Weeks Broker Price Targets For Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Share Trading News05/10/2016 – Ironwood Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Mizuho. They now have a USD 16 price target on the stock. 04/28/2016 – Ironwood Pharmaceuticals, Inc. had its “neutral” rating reiterated by analysts at Wedbush.and more »
05/21/16 06:28 PMAnalysts Observing Trading Stocks: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , Catalent, Inc. (NYSE:CTLT) - Street Updates - Analysts Observing Trading Stocks: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , Catalent, Inc. (NYSE:CTLT)Street UpdatesIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) accumulated +1.78%, closing at $11.42 after floating between $11.10 and $11.43. The company has market capitalization of $1.65B. It has twelve month low of $7.35 and twelve month high of $14.28.and more »
05/20/16 06:53 PMThis Healthcare Stocks is Trending: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - News Oracle - News OracleThis Healthcare Stocks is Trending: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)News OracleThe Company gained 1.91% and finished at $11.22. The daily volume was measured at 2.07 million shares. The 52-week high of the share price is $14.28 and the 52-week low is $7.35. The company has a market cap of $1.65 billion. Its latest closing price ...Revenue Update on Ironwood Pharmaceuticals(NASDAQ:IRWD)Trade CallsIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Updated Broker RatingsRisers & FallersTake a look at Price Fluctuations: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , Trevena, Inc. (NASDAQ:TRVN)Street UpdatesStocks Daily -The Post -PharmiWeb.com (press release)all 8 news articles »
05/20/16 06:53 PMBiotech Movers: Endo International plc (NASDAQ:ENDP) , Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Is stories - Biotech Movers: Endo International plc (NASDAQ:ENDP) , Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Is storiesIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) started out trading at $10.96 and hit to day high price of $11.29 while it touched the day low price of $10.91. Shares have gone up +1.91% to close at $11.22. The company shares changing hands with the ...and more »
05/19/16 06:54 PMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) One-Year Price Target Estimate At $12.71 - Investor Newswire - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) One-Year Price Target Estimate At $12.71Investor NewswireThe 52-week price target of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is set at $12.71 after First Call completed its market based survey. It has estimated EPS of $-0.16 for approaching quarter and $-0.61 for ongoing year. The EPS estimate for next ...and more »
05/19/16 06:54 PMRevenue Update on Ironwood Pharmaceuticals(NASDAQ:IRWD) - Trade Calls - Revenue Update on Ironwood Pharmaceuticals(NASDAQ:IRWD)Trade CallsIronwood Pharmaceuticals(NASDAQ:IRWD) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 9, 2016. Company reported revenue of $66.04M. Analysts estimated a revenue of $53.58M. Earnings per ...Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Updated Broker RatingsRisers & FallersTake a look at Price Fluctuations: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , Trevena, Inc. (NASDAQ:TRVN)Street UpdatesIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Hovering Around $10.80Stocks DailyThe Post -PharmiWeb.com (press release)all 7 news articles »
05/19/16 12:04 PMIRONWOOD PHARMACEUTICALS INC Financials -
05/19/16 07:14 AMInvestor turning cautious on Ironwood -
05/18/16 06:56 PMTake a look at Price Fluctuations: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , Trevena, Inc. (NASDAQ:TRVN) - Street Updates - Take a look at Price Fluctuations: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , Trevena, Inc. (NASDAQ:TRVN)Street UpdatesIronwood Pharmaceuticals, Inc. (IRWD) recently disclosed the presentation of linaclotide-related clinical and preclinical data from the company and its collaborators during Digestive Disease Week® (DDW) 2016 in San Diego, CA, May 21 through May 24, ...Were Analysts Bearish Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) This Week?Franklin IndependentUpgrades And Downgrades For Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Risers & Fallersall 21 news articles »
05/18/16 06:56 PMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Hovering Around $10.80 - Stocks Daily - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Hovering Around $10.80Stocks DailyOn performing technical analysis of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) stock, it is noted that the stock is $0.14 points away +1.28% from its fifty-day MA of $10.82. It is $0.30 or +2.80% away $10.66, the 200-day MA (Moving Average) of stock.and more »
05/18/16 03:32 PMIronwood Pharmaceuticals to Present at 2016 UBS Global Healthcare Conference - [at noodls] - May 18, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 2016 UBS Global Healthcare Conference on Wednesday, May 25, 2016 at ...
05/17/16 11:49 PMNASDAQ:IRWD Stockholder Notice: Investigation of Ironwood Pharmaceuticals, Inc. - An investigation for stockholders of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) over potential securities laws violations was announced. Investors who purchased shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), have certain options and should ...
05/17/16 07:00 AMIronwood Pharmaceuticals to Present Linaclotide Data at Digestive Disease Week® 2016 - [Business Wire] - Ironwood Pharmaceuticals, Inc. today announced the presentation of linaclotide-related clinical and preclinical data from the company and its collaborators during Digestive Disease Week® 2016 in San Diego, CA, May 21 through May 24, 2016.
05/16/16 11:47 PMEcor1 Capital Llc Increased Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) by $12.40 Million as Shares Declined - Wall Street Hints and News - Ecor1 Capital Llc Increased Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) by $12.40 Million as Shares DeclinedWall Street Hints and NewsEcor1 Capital Llc increased its stake in Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) by 150.92% based on its latest 2016Q1 regulatory filing with the SEC. Ecor1 Capital Llc bought 1.24M shares as the company's stock declined 1.17% while stock markets ...and more »
About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals logoIronwood Pharmaceuticals, Inc. is a biotechnology company. The Company's products Linaclotide provides patients and healthcare practitioners with a treatment option for adults in the United States and certain other countries with irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC) and gastrointestinal (GI) disorders. It operates through human therapeutics segment. Linaclotide is also being developed and commercialized in other parts of the world by certain of its partners. It is engaged in developing therapeutic platforms for the treatment of vascular and fibrotic diseases, and refractory gastroesophageal reflux disease (GERD). Its IW-9179 is used for the treatment of gastroparesis and functional dyspepsia. The Company has conducted an exploratory Phase IIa clinical study of IW-3718 in patients with refractory GERD. It has two sGC development candidates, which include IW-1973 and IW-1701.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: IRWD
  • CUSIP: 46333X10
Key Metrics:
  • Previous Close: $12.24
  • 50 Day Moving Average: $12.06
  • 200 Day Moving Average: $10.81
  • P/E Ratio: N/A
  • P/E Growth: -0.51
  • Market Cap: $1.77B
  • Current Quarter EPS Consensus Estimate: $-0.61 EPS
Additional Links:
Ironwood Pharmaceuticals (NASDAQ:IRWD) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha